NM_006231.4(POLE):c.1102G>A (p.Asp368Asn) AND Hereditary cancer-predisposing syndrome
- Germline classification:
- Uncertain significance (1 submission)
- Last evaluated:
- Mar 26, 2018
- Review status:
- Somatic classification
of clinical impact: - None
- Review status:
- Somatic classification
of oncogenicity: - None
- Review status:
- Record status:
- current
- Accession:
- RCV001017317.3
Allele description [Variation Report for NM_006231.4(POLE):c.1102G>A (p.Asp368Asn)]
NM_006231.4(POLE):c.1102G>A (p.Asp368Asn)
Condition(s)
- Name:
- Hereditary cancer-predisposing syndrome
- Synonyms:
- Neoplastic Syndromes, Hereditary; Tumor predisposition; Cancer predisposition; See all synonyms [MedGen]
- Identifiers:
- MONDO: MONDO:0015356; MeSH: D009386; MedGen: C0027672
-
27098_8_172
27098_8_172biosample
-
20925_1_46
20925_1_46biosample
-
27098_8_103
27098_8_103biosample
-
20925_1_94
20925_1_94biosample
-
PREDICTED: Mus musculus zinc metallopeptidase, STE24 (Zmpste24), transcript vari...
PREDICTED: Mus musculus zinc metallopeptidase, STE24 (Zmpste24), transcript variant X1, mRNAgi|1907155651|ref|XM_006503019.2|Nucleotide
Your browsing activity is empty.
Activity recording is turned off.
See more...Assertion and evidence details
Last Updated: Sep 29, 2024